Contracts › 75A50124C00031
75A50124C00031: A Partnership Between the Agreement Recipient, Walgreens, and Biomedical Advanced Research and Development Authority (BARDA) to Enhance Innovation With Decentralized Care Capabilities and to Execute More Efficient and Relevant Clinical Research in Th
Awarded to Walgreen Co. by Office of Assistant Secretary for Preparedness and Response.
$3.5Mobligated
$4.3Mpotential value
28 July 2029current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50124C00031 |
|---|---|
| Awardee | Walgreen Co. |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | IL |
| Offers received | 1 |
| Period of performance | 29 July 2024 to 28 July 2029 |
| Potential end | 28 July 2029 |
| Estimated recompete solicitation | ~Q1 2029 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record